Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promise DM Marks, MJ Shah, AA Patkar, PS Masand, GY Park, CU Pae Current neuropharmacology 7 (4), 331-336, 2009 | 279 | 2009 |
Milnacipran: beyond a role of antidepressant CU Pae, DM Marks, M Shah, C Han, BJ Ham, AA Patkar, PS Masand Clinical neuropharmacology 32 (6), 355-363, 2009 | 61 | 2009 |
Update on optimal use of lisdexamfetamine in the treatment of ADHD V Madaan, V Kolli, DP Bestha, MJ Shah Neuropsychiatric Disease and Treatment, 977-983, 2013 | 14 | 2013 |
Crisis and adolescents: assessments and initial management PM Leverett, S D’Costa, H Cassella, M Shah Primary Care: Clinics in Office Practice 47 (2), 321-329, 2020 | 7 | 2020 |
Rapport Building, Family Dynamics, and Unrecognized Depression M Peters, N Juthani, V Rao Mental Illness Among South Asian Americans: Twenty Culturally Mindful Case …, 2019 | | 2019 |
Psychotic Disorders N Okkels, YX Chu Notes in Psychiatry 1, 62-76, 2016 | | 2016 |